9
3
Cat No. | Product Name | Synonyms | Targets |
---|---|---|---|
T14884 | CBR-5884 | Others , Dehydrogenase | |
CBR-5884 is an selective, active of phosphoglycerate dehydrogenase (PHGDH) inhibitor with an IC50 of 33 μM. CBR-5884 inhibits de novo serine synthesis in cancer cells and is selectively toxic to cancer cell lines with h... | |||
T40063 | CBR-470-1 | Nrf2 | |
CBR-470-1 is a potent inhibitor of glycolytic phosphoglycerate kinase 1 (PGK1) that activates NRF2 by increasing methylglyoxal levels. CBR-470-1 is a non-covalent Nrf2 activator with neuroprotective activity that protect... | |||
T36037 | CBR-470-2 | ||
CBR-470-2, a glycine-substituted analog, exhibits the capacity to activate NRF2 signaling, making it a valuable compound for investigating glycolysis modulation in scientific research [1]. | |||
T26963 | CBR-2092 | TNP2092,CBR2092,TNP-2092,TNP 2092 | |
CBR-2092 is a DNA-directed RNA polymerase and DNA topoisomerase inhibitor. CBR-2092 exhibited rifampin-like potency as an inhibitor of RNA polymerase, was an equipotent (balanced) inhibitor of DNA gyrase and DNA topoisom... | |||
T61192 | CBR-6672 | ||
CBR-6672, a type II NADH dehydrogenase inhibitor, demonstrates potent antimycobacterial activity against mycobacterium tuberculosis (Mtb) with a minimum inhibitory concentration (MIC) of 0.14 μM [1]. | |||
T61035 | CBR-3465 | ||
CBR-3465 is an inhibitor of mycobacterium tuberculosis (Mtb) type II NADH dehydrogenase. The MIC of CBR-3465 against Mtb is 0.16 μM [1]. | |||
T62583 | CBR Agonist-1 | ||
CBR Agonist-1 (27a-cis) is a cannabinoid receptor (CBR) agonist that acts on CB1R (Ki: 0.18 μM) and CB2R (Ki: 1.22 μM). CBR Agonist-1 (27a-cis) can be used to study endogenous cannabinoid system-related diseases. | |||
T62584 | CBR Agonist-2 | ||
CBR Agonist-2 is a CB1 agonist (CB1R; CB1 ligand) (EC50: 960 nM, Ki: 970 nM). CBR Agonist-2 is a promising tool for the study of endogenous cannabinoid system-related diseases involving hCB1R. | |||
T81262 | Rocbrutinib | ||
Rocbrutinib is a Bruton's tyrosine kinase (BTK) inhibitor that exhibits antineoplastic properties [1]. |
Cat No. | Product Name | Species | Expression System |
---|---|---|---|
TMPH-01039 | CBR1 Protein, Human, Recombinant (E. coli, His) | Human | E. coli |
CBR1 Protein, Human, Recombinant (E. coli, His) is expressed in E. coli expression system with N-6xHis tag. The predicted molecular weight is 34.2?kDa and the accession number is P16152. | |||
TMPH-01040 | CBR1 Protein, Human, Recombinant (His) | Human | P. pastoris (Yeast) |
CBR1 Protein, Human, Recombinant (His) is expressed in yeast with N-6xHis tag. The predicted molecular weight is 32.2 kDa and the accession number is P16152. | |||
TMPY-03867 | CBR3 Protein, Human, Recombinant (His) | Human | E. coli |
CBR3, also known as hCBR3, belongs to the short-chain dehydrogenases/reductases (SDR) family. CBR3 is expressed in ovary, pancreas, intestine, colon, kidney, brain, thymus, lung, heart, liver, spleen, leukocyte, prostate... |